The Influence of Alpha1-Adrenoreceptors on Neuropeptide Release from Primary Sensory Neurons of the Lower Urinary Tract

European Urology

Volumn 52, Issue 3, 2007, Pages 901-908

  Trevisani, Marcello ^a   Campi, Barbara ^a   Gatti, Raffaele ^a   André, Eunice ^a   Materazzi, Serena ^b   Nicoletti, Paola ^b   Gazzieri, David ^a   Geppetti, Pierangelo ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alfuzosin; Capsaicin; Cystitis; Sensory nerves; Urinary tract

Indexed keywords

3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CAPSAICIN; CYCLOPHOSPHAMIDE; PHENYLEPHRINE; PROTEIN C FOS; SUBSTANCE P; CALCIUM; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL CULTURE; CONTROLLED STUDY; CYSTITIS; DRUG INHIBITION; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; LUMBAR SPINAL CORD; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; PLASMA PROTEIN EXTRAVASATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SACRAL SPINAL CORD; SENSORY NERVE CELL; SPINAL CORD; SPINAL GANGLION; SPRAGUE DAWLEY RAT; URETHRA; ANIMAL; INNERVATION; INTRACELLULAR FLUID; METABOLISM; PATHOLOGY; SECRETION;

ANIMALS; CALCIUM; CELLS, CULTURED; CYSTITIS; INTRACELLULAR FLUID; MALE; NEURONS, AFFERENT; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; URINARY BLADDER;

EID: 34547169545     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.01.016     Document Type: Article

References (35)

1. Caine M., Perlberg S., and Meretyk S. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol 50 (1978) 551-554
2. Lepor H. The pathophysiology of lower urinary tract symptoms in the ageing male population. Br J Urol 1 (1998) 29-33
3. Milani S., and Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int 4 (2005) 29-36
4. Andersson K.-E. Mode of action of alpha1-adrenoceptor antagonists in the treatment of lower urinary tract symptoms. Br J Urol 85 suppl 2 (2000) 12-18
5. Djavan B., and Marberger M. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 36 (1999) 1-13
6. Rossi C., Kortmann B.B., Sonke G.S., et al. Alpha-blockade improves symptoms suggestive of bladder outlet obstruction but fail to relieve it. J Urol 165 (2001) 38-41
7. Nickel J.C. The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia. Urology 62 3 suppl 1 (2003) 34-41
8. Mehik A., Alas P., Nickel J.C., et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 62 (2003) 425-429
9. Deliveliotis C., Chrisofos M., Gougousis E., et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?. Urology 67 (2006) 35-39
10. Dellabella M., Milanese G., and Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170 6 pt 1 (2003) 2202-2205
11. Nickel J.C., Elhilali M., Emberton M., et al. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 97 (2006) 1242-1246
12. Irani J. Are all alpha-blockers created the same?. Eur Urol 49 (2006) 420-422
13. Geppetti P., and Holzer P. Neurogenic inflammation (1996), CRC Press, Boca Raton
14. de Groat W.C. A neurologic basis for the overactive bladder. Urology 50 6A suppl (1997) 36-52
15. Drummond P.D. Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin. Pain 60 (1995) 311-315
16. Drummond P.D. Enhancement of thermal hyperalgesia by alpha-adrenoceptors in capsaicin-treated skin. J Auton Nerv Syst 69 (1998) 96-102
17. Zou X., Lin Q., and Willis W.D. The effects of sympathectomy on capsaicin-evoked fos expression of spinal dorsal horn GABAergic neurons. Brain Res 958 (2002) 322-329
18. Kinnman E., and Levine J.D. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience 65 (1995) 283-291
19. Lin Q., Zou X., Fang L., and Willis W.D. Sympathetic modulation of acute cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats. J Neurophysiol 89 (2003) 853-861
20. Trevisani M., Smart D., Gunthorpe M.J., et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5 (2002) 546-551
21. Kudo Y., and Ogura A. Glutamate-induced increase in intracellular Ca2+ concentration in isolated hippocampal neurones. Br J Pharmacol 89 (1986) 191-198
22. Glantz S.A. Biostatistics: how to detect, correct and prevent errors in the medical literature. Circulation 61 (1980) 1-7
23. Szallasi A., and Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51 (1999) 159-212
24. Szolcsanyi J. A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 73 (1977) 251-259
25. Fraiser L.H., Kanekal S., and Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42 (1991) 781-795
26. Ahluwalia A., Maggi C.A., Santicioli P., et al. Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br J Pharmacol 111 (1994) 1017-1022
27. Karp J.D., Szczytkowski J.L., and Gentile C.F. Noradrenergic responses of peripheral organs to cyclophosphamide in mice. Life Sci 75 (2004) 2077-2089
28. Onwukeme K.E., Lot T.Y., and Udoh F.V. Influence of denervation on smooth muscle response to repeated administration of cyclophosphamide, cytosine arabinoside, or their combination. Physiol Behav 51 (1992) 661-665
29. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
30. Birder L.A., and de Groat W.C. Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat. J Neurosci 12 (1992) 4878-4889
31. Dinis P., Charrua A., Avelino A., et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 24 (2004) 11253-11263
32. Lanteri-Minet M., Bon K., de Pommery J., et al. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105 (1995) 220-232
33. Vemulakonda V., Somogyi G., Kiss S., et al. Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation. J Urol 173 (2005) 621-624
34. Shoskes D.A., and Katz E. Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 6 (2005) 296-299
35. Mirone V., Imbimbo C., Longo N., and Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol 51 (2007) 57-66